mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |